Oxytocin increases locus coeruleus alpha 2-adrenoreceptor responsiveness in rats

Neuroscience Letters

Volumn 255, Issue 2, 1998, Pages 115-118

  Petersson, Maria ^a,b   Uvnäs Moberg, Kerstin ^b,c   Erhardt, Sophie ^b   Engberg, Göran ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

Alpha 2 adrenoreceptor; Clonidine; Locus coeruleus; Oxytocin

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; OXYTOCIN;

ANIMAL EXPERIMENT; AROUSAL; ARTICLE; BRAIN LEVEL; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; LOCUS CERULEUS; MALE; NERVE CONDUCTION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; STRESS; SUBCUTANEOUS DRUG ADMINISTRATION;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; CLONIDINE; DRUG SYNERGISM; INJECTIONS, INTRAVENOUS; LOCUS COERULEUS; MALE; NEURONS; OXYTOCIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA;

EID: 0032475466     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00729-0     Document Type: Article

References (19)

1. Aghajanian G.K., Cedarbaum J.M., Wang R.Y. Evidence for norepinephrine-mediated collateral inhibition of locus coeruleus neurons. Brain. Res. 136:1977;570-577.
2. Buijs R.M. Vasopressin and oxytocin - their role in neurotransmission. Pharmacol. Ther. 22:1983;127-141.
3. Campese V.M. Neurogenic factors and hypertension in chronic renal failure. J. Nephrol. 10:1997;184-187.
4. Cedarbaum J.M., Aghajanian G.K. Activation of locus coeruleus neurons by peripheral stimuli: modulation by a collateral inhibitory mechanism. Life Sci. 23(13):1978;1383-1392.
5. 2-receptor sensitivity. Life Sci. 30:1982;235-243.
6. Engberg G., Oreland L., Thorén P., Svensson T. Locus coeruleus show reduced alpha 2-receptor responsiveness and decreased basal activity in spontaneously hypertensive rats. J. Neural Transm. 69:1987;71-83.
7. Jones P.M., Robinsson I.C. Differential clearance of neurophysin and neurohypophyseal peptides from the cerebrospinal fluid in conscious guinea pigs. Neuroendocrinology. 34:1982;297-302.
8. Petersson M., Ahlenius S., Wiberg U., Alster P., Uvnäs-Moberg K. Steroid dependent effects of oxytocin on spontaneous locomotor activity in female rats. Brain Res. Bull. 45:1998;301-305.
9. Petersson M., Alster P., Lundeberg T., Uvnäs-Moberg K. Oxytocin causes a long-term decrease of blood pressure in female and male rats. Physiol. Behav. 60(5):1996;1311-1315.
10. Petersson M., Alster P., Lundeberg T., Uvnäs-Moberg K. Oxytocin increases nociceptive thresholds in a long-term perspective in female and male rats. Neurosci. Lett. 212:1996;87-90.
11. Petersson M., Lundeberg T., Uvnäs-Moberg K. Oxytocin decreases blood pressure in male but not in female spontaneously hypertensive rats. J. Auton. Nerv. Syst. 66:1997;15-18.
12. Rajkowski, J., Kubiak, P., Ivanova, S. and Aston-Jones, G., Staterelated activity, reactivity of locus ceruleus neurons in behaving monkeys. In D. Goldstein, G. Eisenhofer and R. McCarty (Eds.), Advances in Pharmacology: Catecholamines Briding Basic Science With Clinical Medicine, Academic Press, San Diego, CA, 1998, pp. 740-744.
13. Richard P., Moos F., Freund-Mercier M.J. Central effects of oxytocin. Physiol. Rev. 71:1991;331-370.
14. Ruiz-Ortega A.J., Ugedo L. The stimulatory effect of clonidine on locus coeruleus neurons of rats with inactivated α2-adrenoceptors: involvement of imidazoline receptors located in nucleus paragigantocellularis. Naunyn-Schmiedeberg's Arch. Pharmacol. 355:1997;288-294.
15. Schneider C., Singewald N., Philippu A. Inhibition of catecholamine (noradrenaline, dopamine) release in the locus coeruleus and the hypothalamus by baroreceptor activation: identification of the involved baroreceptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 352(3):1995;291-296.
16. Uvnäs-Moberg K. Antistress pattern induced by oxytocin. News Physiol. Sci. 98:1998;22-26.
17. Uvnäs-Moberg K., Alster P., Petersson M. Dissociation of oxytocin effects on body weight in two variants of female Sprague-Dawley rats. Integr. Physiol. Behav. Sci. 31:1996;44-55.
18. Uvnäs-Moberg K., Ahlenius S., Hillegaart V., Alster P. High doses of oxytocin cause sedation and low doses cause an anxiolytic like effect in male rat. Pharmacol. Biochem. Behav. 49:1994;101-106.
19. Windle R., Shanks N., Lightman S., Ingram C. Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats. Endocrinology. 138:1997;2829-2834.